STOCK TITAN

Vanda Pharmaceuticals Announces Participation at November 2023 Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Vanda Pharmaceuticals Inc. (VNDA) to participate in Stifel 2023 Healthcare Conference on November 14 and Jefferies 2023 London Healthcare Conference on November 16, with live access on corporate website. Investors advised to register early and access archived conferences for 30 days.
Positive
  • None.
Negative
  • None.

WASHINGTON, Nov. 9, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the following upcoming investor conferences in November 2023:

The Stifel 2023 Healthcare Conference on Tuesday, November 14, 2023. A corporate presentation is scheduled for 4:10 p.m. Eastern Time.

The Jefferies 2023 London Healthcare Conference on Thursday, November 16, 2023. A corporate presentation is scheduled for 2:00 p.m. Greenwich Mean Time (9:00 a.m. Eastern Time).

The corporate presentations given at the Stifel and Jefferies conferences may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the links under Recent Events. Investors are advised to go to the conference websites at least 15 minutes early to register, download, and install any necessary software or presentations. Links to the archived conferences will be available on Vanda's website for a period of approximately 30 days.

About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-november-2023-investor-conferences-301983975.html

SOURCE Vanda Pharmaceuticals Inc.

FAQ

What conferences will Vanda Pharmaceuticals Inc. (VNDA) participate in November 2023?

Vanda Pharmaceuticals Inc. (VNDA) will participate in the Stifel 2023 Healthcare Conference on November 14 and the Jefferies 2023 London Healthcare Conference on November 16.

How can investors access the corporate presentations?

Investors can access the live corporate presentations on Vanda's corporate website under the Investors tab and follow the links under Recent Events. Archived conferences will also be available on the website for approximately 30 days.

What time are the corporate presentations scheduled for?

The corporate presentation at the Stifel conference is scheduled for 4:10 p.m. Eastern Time on November 14, and the presentation at the Jefferies conference is scheduled for 2:00 p.m. Greenwich Mean Time (9:00 a.m. Eastern Time) on November 16.

Vanda Pharmaceuticals Inc.

NASDAQ:VNDA

VNDA Rankings

VNDA Latest News

VNDA Stock Data

297.39M
52.05M
5.21%
91.5%
4.32%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
WASHINGTON

About VNDA

vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.